Immunocore
IMCR
IMCR
129 hedge funds and large institutions have $1.41B invested in Immunocore in 2024 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 48 increasing their positions, 38 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
6% less funds holding
Funds holding: 137 → 129 (-8)
31% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 26
56% less call options, than puts
Call options by funds: $6.62M | Put options by funds: $15M
Holders
129
Holding in Top 10
1
Calls
$6.62M
Puts
$15M
Top Buyers
| 1 | +$109M | |
| 2 | +$21.8M | |
| 3 | +$20.8M | |
| 4 |
Primecap Management
Pasadena,
California
|
+$16.2M |
| 5 |
Two Sigma Advisers
New York
|
+$9.35M |
Top Sellers
| 1 | -$27M | |
| 2 | -$21M | |
| 3 | -$14.4M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$14.2M |
| 5 |
Renaissance Technologies
New York
|
-$11.5M |